Atlantic Innovo News

Atlantic Therapeutics Secures FDA Approval

FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence. Galway, Ireland. 13 November 2018. Seroba’s portfolio company, Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, has announced that the U.S. Food and Drug Administration (FDA) has granted a DeNovo clearance …

Atlantic Therapeutics Secures FDA Approval Read More »